Paul Roberson
Concepts (261)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proto-Oncogene Proteins c-akt | 2 | 2022 | 441 | 0.760 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2022 | 455 | 0.730 |
Why?
| | Long Interspersed Nucleotide Elements | 4 | 2022 | 36 | 0.630 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 320 | 0.610 |
Why?
| | Signal Transduction | 8 | 2026 | 5246 | 0.560 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 4 | 2024 | 141 | 0.430 |
Why?
| | Muscle, Skeletal | 6 | 2022 | 1818 | 0.420 |
Why?
| | Osteoblasts | 9 | 2014 | 145 | 0.400 |
Why?
| | Leucine | 2 | 2022 | 116 | 0.350 |
Why?
| | Whey Proteins | 2 | 2020 | 9 | 0.300 |
Why?
| | Physical Conditioning, Human | 2 | 2020 | 38 | 0.290 |
Why?
| | Apoptosis | 10 | 2026 | 2439 | 0.280 |
Why?
| | Dietary Carbohydrates | 2 | 2020 | 146 | 0.280 |
Why?
| | Bone and Bones | 4 | 2020 | 319 | 0.270 |
Why?
| | Osteogenesis | 7 | 2020 | 205 | 0.260 |
Why?
| | Annexin A1 | 1 | 2026 | 8 | 0.240 |
Why?
| | Ovariectomy | 4 | 2024 | 164 | 0.240 |
Why?
| | RNA, Messenger | 6 | 2024 | 2791 | 0.220 |
Why?
| | Osteocytes | 3 | 2014 | 24 | 0.220 |
Why?
| | Retinal Ganglion Cells | 1 | 2026 | 124 | 0.220 |
Why?
| | Rats, Wistar | 2 | 2024 | 451 | 0.220 |
Why?
| | Dietary Supplements | 2 | 2020 | 587 | 0.220 |
Why?
| | Neuroprotective Agents | 1 | 2026 | 146 | 0.220 |
Why?
| | Monomeric GTP-Binding Proteins | 1 | 2024 | 16 | 0.200 |
Why?
| | Diabetic Retinopathy | 1 | 2026 | 211 | 0.200 |
Why?
| | Wnt Signaling Pathway | 2 | 2018 | 211 | 0.200 |
Why?
| | Rats | 6 | 2024 | 5586 | 0.200 |
Why?
| | Retina | 1 | 2026 | 330 | 0.200 |
Why?
| | Muscular Disorders, Atrophic | 1 | 2022 | 3 | 0.190 |
Why?
| | Hexokinase | 1 | 2022 | 18 | 0.190 |
Why?
| | Hindlimb Suspension | 1 | 2022 | 12 | 0.190 |
Why?
| | Hyperglycemia | 1 | 2026 | 384 | 0.180 |
Why?
| | Follicle Stimulating Hormone | 1 | 2024 | 265 | 0.180 |
Why?
| | Estradiol | 3 | 2024 | 517 | 0.180 |
Why?
| | Muscular Atrophy | 1 | 2022 | 88 | 0.180 |
Why?
| | Myoblasts | 1 | 2022 | 84 | 0.170 |
Why?
| | Military Personnel | 2 | 2020 | 726 | 0.170 |
Why?
| | Glucose | 2 | 2026 | 1053 | 0.170 |
Why?
| | Phosphorylation | 4 | 2022 | 1724 | 0.170 |
Why?
| | Oxidative Stress | 5 | 2026 | 1369 | 0.170 |
Why?
| | Estrogen Receptor alpha | 3 | 2013 | 154 | 0.160 |
Why?
| | Animals | 22 | 2026 | 38107 | 0.160 |
Why?
| | Peptides | 1 | 2026 | 992 | 0.160 |
Why?
| | HEK293 Cells | 1 | 2022 | 750 | 0.150 |
Why?
| | Atrophy | 2 | 2018 | 199 | 0.150 |
Why?
| | Protein Biosynthesis | 1 | 2022 | 449 | 0.150 |
Why?
| | Osteoarthritis | 1 | 2022 | 206 | 0.150 |
Why?
| | Mitochondria | 1 | 2026 | 997 | 0.150 |
Why?
| | Aging | 3 | 2019 | 1996 | 0.150 |
Why?
| | Androgens | 3 | 2018 | 179 | 0.140 |
Why?
| | Body Composition | 2 | 2024 | 689 | 0.140 |
Why?
| | Osteoclasts | 5 | 2013 | 56 | 0.140 |
Why?
| | Nutritive Value | 1 | 2018 | 41 | 0.140 |
Why?
| | Bone Remodeling | 4 | 2014 | 71 | 0.130 |
Why?
| | Energy Metabolism | 1 | 2024 | 930 | 0.130 |
Why?
| | Satellite Cells, Skeletal Muscle | 1 | 2017 | 36 | 0.130 |
Why?
| | Physical Conditioning, Animal | 1 | 2019 | 243 | 0.130 |
Why?
| | Physical Fitness | 1 | 2018 | 209 | 0.120 |
Why?
| | Quadriceps Muscle | 1 | 2017 | 123 | 0.120 |
Why?
| | Bone Density | 6 | 2020 | 494 | 0.110 |
Why?
| | Parathyroid Hormone | 2 | 2008 | 118 | 0.110 |
Why?
| | Estrogens | 4 | 2010 | 364 | 0.110 |
Why?
| | Chromatin | 1 | 2019 | 559 | 0.110 |
Why?
| | Resistance Training | 1 | 2017 | 186 | 0.110 |
Why?
| | Muscle Contraction | 1 | 2017 | 438 | 0.110 |
Why?
| | Inflammation | 1 | 2026 | 2919 | 0.110 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2021 | 665 | 0.110 |
Why?
| | Cannabis | 1 | 2021 | 521 | 0.100 |
Why?
| | bcl-2 Homologous Antagonist-Killer Protein | 1 | 2014 | 14 | 0.100 |
Why?
| | bcl-2-Associated X Protein | 1 | 2014 | 53 | 0.100 |
Why?
| | Heart Defects, Congenital | 1 | 2021 | 923 | 0.100 |
Why?
| | Prednisolone | 2 | 2011 | 65 | 0.090 |
Why?
| | Cell Proliferation | 2 | 2017 | 2502 | 0.090 |
Why?
| | Mice | 14 | 2022 | 18297 | 0.090 |
Why?
| | Alendronate | 3 | 2009 | 14 | 0.090 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 209 | 0.090 |
Why?
| | Osteoprotegerin | 1 | 2011 | 24 | 0.090 |
Why?
| | Cell Nucleus | 2 | 2013 | 584 | 0.080 |
Why?
| | Periosteum | 1 | 2008 | 14 | 0.070 |
Why?
| | Receptors, Androgen | 2 | 2018 | 149 | 0.070 |
Why?
| | Bone Density Conservation Agents | 1 | 2009 | 83 | 0.070 |
Why?
| | Forkhead Box Protein O1 | 2 | 2021 | 36 | 0.070 |
Why?
| | Double-Blind Method | 3 | 2020 | 2070 | 0.060 |
Why?
| | Mitosis | 1 | 2008 | 195 | 0.060 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2019 | 216 | 0.060 |
Why?
| | Femur | 3 | 2014 | 264 | 0.060 |
Why?
| | Glucocorticoids | 1 | 2011 | 536 | 0.060 |
Why?
| | Organ Size | 3 | 2018 | 465 | 0.060 |
Why?
| | Gonadal Steroid Hormones | 1 | 2007 | 143 | 0.060 |
Why?
| | Bone Resorption | 3 | 2020 | 81 | 0.060 |
Why?
| | Humans | 14 | 2026 | 146342 | 0.060 |
Why?
| | Stem Cells | 3 | 2013 | 613 | 0.050 |
Why?
| | Cell Differentiation | 3 | 2010 | 1982 | 0.050 |
Why?
| | Cell Cycle Proteins | 2 | 2022 | 630 | 0.050 |
Why?
| | Adipose Tissue, White | 1 | 2024 | 43 | 0.050 |
Why?
| | Calcium | 3 | 2020 | 1181 | 0.050 |
Why?
| | Multienzyme Complexes | 1 | 2003 | 65 | 0.050 |
Why?
| | Cysteine Endopeptidases | 1 | 2003 | 81 | 0.050 |
Why?
| | Cell Survival | 1 | 2026 | 1105 | 0.050 |
Why?
| | Eukaryotic Initiation Factors | 1 | 2022 | 13 | 0.050 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2022 | 33 | 0.050 |
Why?
| | Young Adult | 4 | 2022 | 14330 | 0.050 |
Why?
| | Nucleotidyltransferases | 1 | 2022 | 30 | 0.040 |
Why?
| | Time Factors | 4 | 2018 | 7109 | 0.040 |
Why?
| | Ovary | 1 | 2024 | 236 | 0.040 |
Why?
| | Amino Acids | 2 | 2024 | 515 | 0.040 |
Why?
| | Female | 14 | 2024 | 79499 | 0.040 |
Why?
| | Body Weight | 2 | 2024 | 968 | 0.040 |
Why?
| | Cell Line | 3 | 2017 | 2814 | 0.040 |
Why?
| | Adiposity | 2 | 2018 | 533 | 0.040 |
Why?
| | Transcription Factors | 2 | 2013 | 1730 | 0.040 |
Why?
| | Mammals | 1 | 2022 | 288 | 0.040 |
Why?
| | Neoplasm Proteins | 1 | 2003 | 444 | 0.040 |
Why?
| | Cells, Cultured | 4 | 2013 | 4118 | 0.040 |
Why?
| | Male | 10 | 2024 | 73396 | 0.040 |
Why?
| | Aminoimidazole Carboxamide | 1 | 2019 | 13 | 0.040 |
Why?
| | Biomarkers | 2 | 2022 | 4340 | 0.040 |
Why?
| | Calcitonin | 1 | 1999 | 26 | 0.040 |
Why?
| | Ribonucleotides | 1 | 2019 | 27 | 0.040 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2022 | 429 | 0.040 |
Why?
| | Cyclophilin A | 1 | 2019 | 28 | 0.040 |
Why?
| | Rotenone | 1 | 2019 | 21 | 0.040 |
Why?
| | Hydroxamic Acids | 1 | 2019 | 96 | 0.040 |
Why?
| | Diphosphonates | 1 | 1999 | 68 | 0.040 |
Why?
| | Caffeine | 1 | 2019 | 77 | 0.040 |
Why?
| | Primary Cell Culture | 1 | 2019 | 173 | 0.040 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2019 | 131 | 0.040 |
Why?
| | Mice, Inbred C57BL | 4 | 2013 | 6034 | 0.030 |
Why?
| | Trenbolone Acetate | 1 | 2018 | 9 | 0.030 |
Why?
| | Wnt-5a Protein | 1 | 2018 | 25 | 0.030 |
Why?
| | Cyclins | 1 | 1998 | 77 | 0.030 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2019 | 193 | 0.030 |
Why?
| | Receptors, Estrogen | 1 | 2001 | 406 | 0.030 |
Why?
| | Knee Joint | 1 | 2022 | 453 | 0.030 |
Why?
| | Orchiectomy | 1 | 2018 | 72 | 0.030 |
Why?
| | RNA-Directed DNA Polymerase | 1 | 2017 | 35 | 0.030 |
Why?
| | Endonucleases | 1 | 2017 | 35 | 0.030 |
Why?
| | Rats, Inbred F344 | 1 | 2018 | 266 | 0.030 |
Why?
| | Reverse Transcriptase Inhibitors | 1 | 2017 | 89 | 0.030 |
Why?
| | Transcriptome | 1 | 2024 | 1068 | 0.030 |
Why?
| | Testosterone | 2 | 2018 | 419 | 0.030 |
Why?
| | Physical Endurance | 1 | 2018 | 278 | 0.030 |
Why?
| | Vitamin D | 1 | 2020 | 402 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 1998 | 328 | 0.030 |
Why?
| | Steroid 16-alpha-Hydroxylase | 1 | 1996 | 1 | 0.030 |
Why?
| | Nutritional Status | 1 | 2018 | 346 | 0.030 |
Why?
| | Aryl Hydrocarbon Hydroxylases | 1 | 1996 | 45 | 0.030 |
Why?
| | Proteomics | 1 | 2022 | 1203 | 0.030 |
Why?
| | Lead | 1 | 1996 | 71 | 0.030 |
Why?
| | Down-Regulation | 1 | 2017 | 614 | 0.030 |
Why?
| | Muscle Strength | 1 | 2018 | 340 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2022 | 3125 | 0.030 |
Why?
| | Up-Regulation | 1 | 1998 | 841 | 0.030 |
Why?
| | Liver | 1 | 2024 | 1864 | 0.030 |
Why?
| | Reproduction | 1 | 1996 | 209 | 0.030 |
Why?
| | Smoking | 1 | 2021 | 1486 | 0.030 |
Why?
| | DNA Methylation | 1 | 2019 | 725 | 0.030 |
Why?
| | Interleukin-6 | 1 | 1998 | 784 | 0.030 |
Why?
| | Maternal Exposure | 1 | 1996 | 189 | 0.030 |
Why?
| | Sp7 Transcription Factor | 1 | 2013 | 7 | 0.020 |
Why?
| | Porosity | 1 | 2014 | 95 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2021 | 3647 | 0.020 |
Why?
| | Forkhead Box Protein O3 | 1 | 2013 | 18 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2013 | 83 | 0.020 |
Why?
| | Adipogenesis | 1 | 2013 | 56 | 0.020 |
Why?
| | Gene Knockout Techniques | 1 | 2013 | 122 | 0.020 |
Why?
| | Risk Assessment | 1 | 2021 | 3712 | 0.020 |
Why?
| | Bone Marrow | 1 | 2013 | 310 | 0.020 |
Why?
| | Uterus | 1 | 2013 | 227 | 0.020 |
Why?
| | Aged | 2 | 2022 | 26432 | 0.020 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 1 | 2011 | 54 | 0.020 |
Why?
| | Spine | 1 | 2013 | 184 | 0.020 |
Why?
| | Transcription, Genetic | 2 | 2010 | 1432 | 0.020 |
Why?
| | HeLa Cells | 2 | 2003 | 636 | 0.020 |
Why?
| | Pregnancy | 2 | 2021 | 7230 | 0.020 |
Why?
| | Src Homology 2 Domain-Containing, Transforming Protein 1 | 1 | 2010 | 10 | 0.020 |
Why?
| | Shc Signaling Adaptor Proteins | 1 | 2010 | 10 | 0.020 |
Why?
| | Smad1 Protein | 1 | 2010 | 17 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2013 | 610 | 0.020 |
Why?
| | Glutathione Reductase | 1 | 2010 | 24 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 2599 | 0.020 |
Why?
| | Adult | 3 | 2021 | 41087 | 0.020 |
Why?
| | Gene Knock-In Techniques | 1 | 2010 | 60 | 0.020 |
Why?
| | Exercise | 1 | 2022 | 2213 | 0.020 |
Why?
| | Bone Morphogenetic Protein 2 | 1 | 2010 | 77 | 0.020 |
Why?
| | Homeostasis | 1 | 2014 | 646 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 174 | 0.020 |
Why?
| | Tartrate-Resistant Acid Phosphatase | 1 | 2009 | 6 | 0.020 |
Why?
| | Acid Phosphatase | 1 | 2009 | 15 | 0.020 |
Why?
| | Thymidine Kinase | 1 | 2008 | 14 | 0.020 |
Why?
| | Models, Biological | 2 | 2008 | 1761 | 0.020 |
Why?
| | Ganciclovir | 1 | 2008 | 51 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2010 | 759 | 0.020 |
Why?
| | Membrane Glycoproteins | 2 | 2003 | 495 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2134 | 0.020 |
Why?
| | Isoenzymes | 1 | 2009 | 294 | 0.020 |
Why?
| | Cell Count | 1 | 2008 | 315 | 0.020 |
Why?
| | Collagen Type I | 1 | 2008 | 144 | 0.020 |
Why?
| | Infant | 1 | 2021 | 10114 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 10921 | 0.020 |
Why?
| | DNA Replication | 1 | 2008 | 248 | 0.020 |
Why?
| | Postmenopause | 1 | 2009 | 394 | 0.020 |
Why?
| | Linear Models | 1 | 2009 | 857 | 0.010 |
Why?
| | Biopsy | 1 | 2009 | 1075 | 0.010 |
Why?
| | Phenotype | 1 | 2013 | 3206 | 0.010 |
Why?
| | Middle Aged | 2 | 2022 | 36619 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2009 | 2022 | 0.010 |
Why?
| | Receptor Activator of Nuclear Factor-kappa B | 1 | 2003 | 9 | 0.010 |
Why?
| | bcl-Associated Death Protein | 1 | 2003 | 10 | 0.010 |
Why?
| | Dactinomycin | 1 | 2003 | 24 | 0.010 |
Why?
| | RANK Ligand | 1 | 2003 | 29 | 0.010 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2003 | 45 | 0.010 |
Why?
| | Antioxidants | 1 | 2007 | 544 | 0.010 |
Why?
| | Culture Media, Conditioned | 1 | 2003 | 112 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2021 | 17438 | 0.010 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 125 | 0.010 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 146 | 0.010 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2003 | 155 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 237 | 0.010 |
Why?
| | Child | 1 | 2021 | 22693 | 0.010 |
Why?
| | src Homology Domains | 1 | 2001 | 34 | 0.010 |
Why?
| | Blotting, Western | 1 | 2003 | 1177 | 0.010 |
Why?
| | Estrogen Receptor beta | 1 | 2001 | 40 | 0.010 |
Why?
| | Models, Genetic | 1 | 2003 | 540 | 0.010 |
Why?
| | src-Family Kinases | 1 | 2001 | 93 | 0.010 |
Why?
| | Cytoplasm | 1 | 2001 | 253 | 0.010 |
Why?
| | Kinetics | 1 | 2003 | 1553 | 0.010 |
Why?
| | Etidronic Acid | 1 | 1999 | 3 | 0.010 |
Why?
| | In Situ Nick-End Labeling | 1 | 1999 | 120 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2001 | 288 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2003 | 728 | 0.010 |
Why?
| | Etoposide | 1 | 1999 | 169 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2001 | 1041 | 0.010 |
Why?
| | Transcriptional Activation | 1 | 2001 | 369 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 22557 | 0.010 |
Why?
| | Cytokine Receptor gp130 | 1 | 1998 | 11 | 0.010 |
Why?
| | Skull | 1 | 1999 | 162 | 0.010 |
Why?
| | Osteocalcin | 1 | 1998 | 37 | 0.010 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1998 | 104 | 0.010 |
Why?
| | Osteoporosis, Postmenopausal | 1 | 1998 | 41 | 0.010 |
Why?
| | Oligonucleotides, Antisense | 1 | 1998 | 122 | 0.010 |
Why?
| | Binding Sites | 1 | 2001 | 1309 | 0.010 |
Why?
| | Dexamethasone | 1 | 1999 | 368 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2001 | 693 | 0.010 |
Why?
| | RNA | 1 | 2003 | 926 | 0.010 |
Why?
| | Steroid Hydroxylases | 1 | 1996 | 20 | 0.010 |
Why?
| | Genitalia, Male | 1 | 1996 | 11 | 0.010 |
Why?
| | Embryonic and Fetal Development | 1 | 1996 | 90 | 0.010 |
Why?
| | Sexual Maturation | 1 | 1996 | 49 | 0.010 |
Why?
| | Fibroblasts | 1 | 2001 | 1034 | 0.010 |
Why?
| | Antigens, CD | 1 | 1998 | 560 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 1998 | 1361 | 0.010 |
Why?
| | Luteinizing Hormone | 1 | 1996 | 206 | 0.010 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 1996 | 163 | 0.010 |
Why?
| | Base Sequence | 1 | 1998 | 2123 | 0.010 |
Why?
| | Sex Factors | 1 | 2001 | 2107 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 1999 | 1224 | 0.010 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 1998 | 530 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 1998 | 1242 | 0.010 |
Why?
| | Vagina | 1 | 1996 | 202 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 1996 | 2537 | 0.000 |
Why?
|
|
Roberson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|